buserelin has been researched along with leuprolide in 105 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (21.90) | 18.7374 |
| 1990's | 42 (40.00) | 18.2507 |
| 2000's | 26 (24.76) | 29.6817 |
| 2010's | 12 (11.43) | 24.3611 |
| 2020's | 2 (1.90) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuyama, A; Minaguchi, H; Shirasu, K; Uemura, T; Yanagisawa, T | 1 |
| Balasch, J; Civico, S; Jové, IC; Moreno, V; Puerto, B; Vanrell, JA | 1 |
| Cohen, K; Monroziès, X; Oustry, P; Parinaud, J; Perineau, M; Rème, JM | 1 |
| Boesten, WH; Kamphuis, J; Meijer, EM; Schoemaker, HE; Sonke, T; van den Tweel, WJ | 1 |
| Miró, F; Pellicer, A; Sampaio, MC; Tarin, JJ | 1 |
| Monroziès, X; Oustry, P; Parinaud, J; Perineau, M; Pontonnier, G; Rème, JM | 1 |
| Andreoli, C; D'Addato, F; Repinto, A | 1 |
| Altchek, A | 1 |
| Chase, JS; Check, JH; Nowroozi, K | 1 |
| Ando, M; Koyama, N; Nakamura, Y; Nanno, T; Shiokawa, S; Yoshimura, Y | 1 |
| Benito, JA; Corcóstegui, B; Mendoza, MR; Tejada, MI | 1 |
| Ando, M; Jinno, M; Koyama, N; Nakamura, Y; Nanno, T; Oda, T; Shiokawa, S; Yoshimura, Y | 1 |
| Schmidt, JD | 1 |
| Moghissi, KS | 1 |
| Armengol, J; Bella, F; Calaf, J; Espaulella, J; Lain, JM | 1 |
| Taylor, TK | 1 |
| Denis, L | 1 |
| Ando, M; Nakamura, Y; Nanno, T; Suzuki, M; Ubukata, Y; Yamada, H; Yoshimura, Y | 1 |
| Benito, JA; Corcóstegui, B; Mendoza, R; Tejada, MI | 1 |
| Ando, M; Nakamura, Y; Nanno, T; Oda, T; Suzuki, M; Ubukata, Y; Yamada, H; Yoshimura, Y | 1 |
| Barbieri, RL; Friedman, AJ; Lobel, SM; Rein, MS | 1 |
| Ikemoto, I; Machida, T | 1 |
| Liang, SG; Mizuno, M; Taketani, Y; Yano, T | 1 |
| Hirasawa, K; Honma, Y; Isurugi, K; Kondo, Y; Oyamatsu, T | 1 |
| Chodak, GW | 1 |
| Irie, S; Matsumura, Y; Nagai, A; Nanba, K; Ohashi, T; Ohashi, Y; Ohmori, H; Tanahashi, T; Yamashita, Y | 1 |
| Terakawa, N | 1 |
| Ataya, KM; Blacker, CM; Latif, ZA; Mutchnick, MG; Sakr, W | 1 |
| Lemay, A | 1 |
| Conn, PM; Dalati, B; Jennes, L | 1 |
| Eisenberger, MA; Friedman, MA; O'Dwyer, PJ | 1 |
| Calle Fernández, JR; Rubio Herrera, MA | 1 |
| Garnick, MB; Seely, JH; Swanson, LJ | 1 |
| Koiter, TR; Moes, H; Schuiling, GA | 1 |
| Harvey, H; Lipton, A; Manni, A; Max, D; Santen, R | 1 |
| Hickey, D; Soloway, MS; Todd, B | 1 |
| Belanger, A; Borsanyi, JP; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacourciere, Y; Monfette, G | 1 |
| Lynch, JH; O'Brien, WM | 1 |
| Paulson, DF | 1 |
| Burk, K; Gropp, C | 1 |
| Bélanger, A; Cusan, L; Kelly, PA; Labrie, F; Lemay, A; Pelletier, G; Raynaud, JP; Reeves, J; Séguin, C | 1 |
| Arimura, A; Coy, DH; Schally, AV | 1 |
| Soloway, MS | 1 |
| Labrie, F; Mary, I; Moguilewsky, M; Mouren, M; Raynaud, JP | 1 |
| Colombi, C; Dal Prato, L; Fabbri, R; Filicori, M; Flamigni, C; Porcu, E; Seracchioli, R | 1 |
| Lieberman, BA; Matson, PL; Troup, SA; Wada, I | 1 |
| Healy, DL | 1 |
| Kojima, M; Ohe, H; Watanabe, H | 1 |
| Bontis, J; Grimbizis, G; Lagos, S; Mantalenakis, S; Pados, G; Pournaropoulos, F; Tarlatzis, BC | 1 |
| Van Leusden, HA | 1 |
| Bili, H; Bontis, J; Lagos, S; Mantalenakis, S; Tarlatzis, BC; Vatev, I | 1 |
| Buller, RE; Conn, PM; Connor, JP | 1 |
| Arnone, R; Capelli, M; Cognigni, G; Dellai, P; Falbo, A; Filicori, M; Flamigni, C | 1 |
| Kamoi, K; Kojima, M; Naya, Y; Ohe, H; Terasaki, T; Watanabe, H | 1 |
| Lambalk, CB; van Hooff, MH | 1 |
| Gilliland, GB; Seeras, RC | 1 |
| Bühler, K; Gärtner, A; Kuhlmann, M; Regidor, PA; Schindler, AE; Schindler, EM | 1 |
| Cédrin-Durnerin, I; Hugues, JN | 1 |
| Horibe, S; Imai, A; Takagi, A; Takagi, H; Tamaya, T | 1 |
| Atared, AM; Coskun, S; Hollanders, JM; Jaroudi, KA; Roca, GL | 1 |
| Donhuijsen, K; Leder, LD; Regidor, PA; Ruwe, M; Schindler, AE | 1 |
| Baillie, HS; Dada, T; Salha, O; Sharma, V | 1 |
| Eldar-Geva, T; Garcia-Velasco, JA; Healy, DL; Leader, A; Lindenberg, S; Mikkelsen, AL; Out, HJ; Pellicer, A; Rodriguez-Escudero, FJ | 1 |
| Barash, A; Weissman, A | 1 |
| Cook, T; Sheridan, WP | 1 |
| Imai, A; Takagi, A; Tamaya, T | 1 |
| Famelos, M; Gabbe, M; Healy, D; Kovacs, G; Platteau, P | 1 |
| Ling, FW | 1 |
| Ogita, S; Tanaka, T; Umesaki, N | 1 |
| Kikuchi, I; Kobori, H; Mitsuhashi, N; Sato, Y; Takeuchi, H | 1 |
| Aoki, R; Banno, K; Iwata, T; Kubushiro, K; Nozawa, S; Tsukazaki, K; Yamashita, H | 1 |
| Emperaire, JC; Parneix, I; Parneix, P; Ruffie, A | 1 |
| Fang, F; Huang, M | 1 |
| Haba, T; Honda, KI; Ishiko, O; Kawamura, N; Morimura, M; Ogita, S; Sumi, T; Wakasa, K | 1 |
| Mannaerts, BM; Out, HJ | 1 |
| Arisaka, O; Nakayama, Y; Tadokoro, R; Tokita, A; Yamashiro, Y | 1 |
| Al-Mizyen, E; Al-Shawaf, T; Bhide, M; El-Nemr, A; Gillott, C; Grudzinskas, JG; Khalifa, Y; Lower, AM | 1 |
| Fushiki, S; Honjo, H; Ishihara, H; Kado, N; Kitawaki, J; Koshiba, H | 1 |
| Fujimoto, S; Hareyama, H; Hoshi, N; Kataoka, S; Kudo, M; Sakuragi, N; Yamada, H | 1 |
| Arnold, S; Hubler, M; Jöchle, W; Piché, CA; Reichler, IM; Trigg, TE | 1 |
| Kinoshita, K; Seko, M; Takeuchi, H; Tokita, A | 1 |
| Horiguchi, F; Ishitani, K; Makita, K; Nozawa, S; Ohta, H | 1 |
| Barbara, AM; Fleshner, N; Gray, RE; Sinding, C; Trosztmer, C; Wassersug, RJ | 1 |
| Ayabe, T | 1 |
| Noguchi, S; Taguchi, T | 1 |
| Tanaka, T | 1 |
| Furui, T; Imai, A; Ohno, T; Sugiyama, M; Tamaya, T | 1 |
| Carstensen, A; Mundhenke, C; Schollmeyer, T | 1 |
| Cheon, KW; Choi, BC; Lee, HB; Lee, SC; Song, SJ; Yoo, KJ; Yu, SY | 1 |
| Brower, V | 1 |
| Akira, S; Ichikawa, M; Iwasaki, N; Kuwabara, Y; Mine, K; Tajima, H; Takeshita, T | 1 |
| Furui, T; Imai, A; Suzuki, N; Yamamoto, A | 1 |
| Carsi, M; Iannazzo, S; Perachino, M; Pradelli, L | 1 |
| Almeling, S; Holzgrabe, U; Nap, CJ | 1 |
| Bhattacharya, S; Gibreel, A; Maheshwari, A; Siristatidis, CS | 1 |
| Faustmann, T; Gerlinger, C; Hassall, JJ; Seitz, C | 1 |
| Hamm, J; Morris, WJ; Pickles, T; Schreiber, WE; Tyldesley, S | 1 |
| Anikus'ko, NF; Liubota, II; Liubota, RV; Shchepotin, IB; Zotov, AS | 1 |
| Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S | 1 |
| Ichigo, S; Imai, A; Matsunami, K; Takagi, H | 1 |
| Basios, G; Bhattacharya, S; Gibreel, A; Maheshwari, A; Siristatidis, CS | 1 |
| Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G | 1 |
| Cooks, RG; Hu, Y; Li, Y; Liu, Y; Logsdon, DL; Zhao, Y | 1 |
| Cicione, A; De Nunzio, C; Franco, A; Gravina, C; Grimaldi, MC; Guercio, A; Lombardo, R; Nacchia, A; Tema, G; Tubaro, A | 1 |
22 review(s) available for buserelin and leuprolide
| Article | Year |
|---|---|
Management of fibroids.
Topics: Buserelin; Female; Goserelin; Humans; Hysteroscopy; Leiomyoma; Leuprolide; Methods; Uterine Neoplasms | 1992 |
Hormonal therapy before surgical treatment for uterine leiomyomas.
Topics: Antineoplastic Agents; Buserelin; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Nafarelin; Premedication; Uterine Neoplasms | 1991 |
Endocrine therapy for advanced stage D prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Estradiol Congeners; Goserelin; Humans; Leuprolide; Male; Orchiectomy; Prostatic Neoplasms | 1991 |
Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.
Topics: Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms | 1989 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Gonadotropin-releasing hormone analogs and prostatic cancer.
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate | 1988 |
LH-RH agonists and antagonists.
Topics: Animals; Buserelin; Contraception; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Leuprolide; Male; Ovary; Pregnancy; Triptorelin Pamoate | 1980 |
Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose.
Topics: Buserelin; Dose-Response Relationship, Drug; Drug Delivery Systems; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Leuprolide; Menstrual Cycle; Nafarelin; Structure-Activity Relationship; Triptorelin Pamoate | 1994 |
[Revisiting GnRH analog protocols II. Strategy for poor responders].
Topics: Animals; Buserelin; Clinical Protocols; Drug Administration Schedule; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Ovulation Induction; Pregnancy; Pregnancy Outcome | 1997 |
Development of GnRH antagonists for prostate cancer: new approaches to treatment.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Testosterone | 2000 |
Should we still advise infertile couples to use (barrier) contraception before IVF down-regulation?
Topics: Buserelin; Down-Regulation; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Infertility; Leuprolide; Male; Nafarelin; Outcome Assessment, Health Care; Pregnancy; Retrospective Studies | 2000 |
Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Buserelin; Danazol; Depressive Disorder; Diagnosis, Differential; Estrogen Antagonists; Female; Gynecology; Humans; Leuprolide; Medical Records; Obstetrics; Ovulation; Practice Patterns, Physicians'; Premenstrual Syndrome; Primary Health Care; Professional Practice; Psychiatric Status Rating Scales; Severity of Illness Index | 2000 |
[Prevention and therapy of side effects of gonadotropin-releasing hormone agonist in patients with endometriosis].
Topics: Buserelin; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Nafarelin; Osteoporosis | 1999 |
The gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data.
Topics: Adolescent; Adult; Buserelin; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leuprolide; Male; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 2002 |
[An outline of GnRH analogue].
Topics: Animals; Buserelin; Drug Design; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Phenylurea Compounds; Pyrimidinones; Thymine | 2006 |
[Clinical applications of GnRHa in breast cancer].
Topics: Breast Neoplasms; Buserelin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Ovariectomy; Randomized Controlled Trials as Topic; Tamoxifen | 2006 |
[Precocious puberty].
Topics: Biomarkers; Buserelin; Diagnosis, Differential; Diagnostic Imaging; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Male; Prognosis; Puberty, Precocious | 2006 |
Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy.
Topics: Aged; Antineoplastic Agents, Hormonal; Buserelin; Cost-Benefit Analysis; Decision Trees; Drug Costs; Gonadotropin-Releasing Hormone; Goserelin; Humans; Italy; Leuprolide; Male; Models, Econometric; Proportional Hazards Models; Prostatic Neoplasms; Survival Analysis; Triptorelin Pamoate | 2011 |
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Topics: Buserelin; Clinical Protocols; Drug Administration Schedule; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Live Birth; Luteinizing Hormone; Ovulation Induction; Pituitary Gland; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted; Triptorelin Pamoate | 2011 |
Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials.
Topics: Asian People; Buserelin; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Japan; Leuprolide; Nandrolone; Treatment Outcome; White People | 2012 |
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Topics: Buserelin; Clinical Protocols; Drug Administration Schedule; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Live Birth; Luteinizing Hormone; Ovulation Induction; Pituitary Gland; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted; Triptorelin Pamoate | 2015 |
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate | 2017 |
16 trial(s) available for buserelin and leuprolide
| Article | Year |
|---|---|
The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Corpus Luteum; Cryopreservation; Embryo, Mammalian; Estradiol; Female; Fertilization in Vitro; Humans; Infertility; Leuprolide; Oocytes; Pregnancy; Prospective Studies; Random Allocation | 1992 |
Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program.
Topics: Buserelin; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Ovarian Follicle; Ovary; Stimulation, Chemical; Time Factors; Triptorelin Pamoate | 1992 |
Comparison of short versus long-term leuprolide acetate--human menopausal gonadotrophin hyperstimulation in in-vitro fertilization patients.
Topics: Adult; Buserelin; Drug Administration Schedule; Female; Fertilization in Vitro; Humans; Leuprolide; Luteal Phase; Menotropins; Prospective Studies; Random Allocation | 1992 |
Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Topics: Buserelin; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Leuprolide; Middle Aged; Pilot Projects; Preoperative Care; Progestins; Time Factors; Uterine Neoplasms; Uterus | 1990 |
Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.
Topics: Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms | 1989 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Gonadotropin-releasing hormone analogs and prostatic cancer.
Topics: Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate | 1988 |
Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms; Triptorelin Pamoate | 1986 |
Comparison between depot leuprorelin and daily buserelin in IVF.
Topics: Abortion, Spontaneous; Adult; Buserelin; Delayed-Action Preparations; Drug Administration Schedule; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Infertility, Female; Injections, Subcutaneous; Leuprolide; Luteal Phase; Luteinizing Hormone; Male; Pituitary Gland, Anterior; Pregnancy; Pregnancy Rate; Superovulation; Treatment Outcome | 1995 |
Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Gonadotropins; Humans; Leuprolide; Menotropins; Menstrual Cycle; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Outcome; Radioimmunoassay; Risk Factors | 1995 |
Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques.
Topics: Adult; Buserelin; Depression, Chemical; Drug Administration Schedule; Embryo Implantation; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Follicular Phase; Gonadotropins, Pituitary; Humans; Leuprolide; Luteal Phase; Menotropins; Ovulation Induction; Pituitary Gland, Anterior; Pregnancy; Prospective Studies; Secretory Rate; Treatment Outcome; Zygote Intrafallopian Transfer | 1994 |
[Endometriosis: clinical, histological and morphometric findings before and after Gn-RH agonist therapy].
Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Endometriosis; Fallopian Tubes; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Treatment Outcome | 1998 |
A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study.
Topics: Administration, Inhalation; Adult; Buserelin; Delayed-Action Preparations; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormones; Humans; Injections, Subcutaneous; Leuprolide; Nafarelin; Pregnancy; Pregnancy Rate; Prospective Studies | 1999 |
A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation.
Topics: Buserelin; Chorionic Gonadotropin; Double-Blind Method; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Follicle Stimulating Hormone, Human; Humans; Leuprolide; Microinjections; Nafarelin; Ovulation Induction; Pregnancy; Progesterone; Prospective Studies; Recombinant Proteins | 1999 |
A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Endometriosis; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Leiomyoma; Leuprolide; Luteinizing Hormone; Male; Middle Aged; Ovarian Diseases; Prospective Studies; Treatment Outcome; Ultrasonography; Uterine Diseases; Uterine Hemorrhage | 2000 |
Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study.
Topics: Administration, Intranasal; Adult; Buserelin; Embryo Transfer; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Menotropins; Nafarelin; Oocytes; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome | 2002 |
70 other study(ies) available for buserelin and leuprolide
| Article | Year |
|---|---|
Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.
Topics: Animals; Buserelin; Cells, Cultured; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Leuprolide; Luteinizing Hormone; Male; Nafarelin; Pituitary Gland; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, LHRH; RNA, Messenger | 1992 |
Influence of ovarian cysts on the results of in vitro fertilization.
Topics: Buserelin; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Leuprolide; Luteinizing Hormone; Menotropins; Ovarian Cysts; Ovarian Follicle; Pregnancy; Retrospective Studies; Triptorelin Pamoate | 1992 |
New developments in the synthesis of natural and unnatural amino acids.
Topics: Amino Acid Sequence; Amino Acids; Buserelin; Gonadotropin-Releasing Hormone; Kinetics; Leucyl Aminopeptidase; Leuprolide; Molecular Sequence Data; Peptides; Pseudomonas putida; Stereoisomerism; Substrate Specificity | 1992 |
Steroidogenesis in vitro of human granulosa-luteal cells pretreated in vivo with two gonadotropin releasing hormone analogs employing different protocols.
Topics: Buserelin; Cells, Cultured; Chorionic Gonadotropin; Clomiphene; Female; Fertilization in Vitro; Granulosa Cells; Humans; Leuprolide; Luteal Cells; Progesterone | 1992 |
Pre-surgical treatment of uterine myomas with LH-RH agonists.
Topics: Administration, Inhalation; Adult; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Chemotherapy, Adjuvant; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Injections, Intramuscular; Leiomyoma; Leuprolide; Luteinizing Hormone; Middle Aged; Triptorelin Pamoate; Uterine Neoplasms | 1992 |
Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle.
Topics: Animals; Buserelin; Cellular Senescence; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Leuprolide; Meiosis; Oocytes; Ovarian Follicle; Prostaglandins; Rabbits | 1992 |
Factors associated with premature chromosome condensation (PCC) following in vitro fertilization.
Topics: Adult; Buserelin; Cell Cycle; Chromosomes; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Karyotyping; Leuprolide; Menotropins; Oocytes; Ovulation Induction | 1992 |
Protein kinase C mediates gonadotropin-releasing hormone agonist-induced meiotic maturation of follicle-enclosed rabbit oocytes.
Topics: Alkaloids; Animals; Buserelin; Dose-Response Relationship, Drug; Female; Gonadotropin-Releasing Hormone; Leuprolide; Meiosis; Oocytes; Oogenesis; Ovarian Follicle; Phorbol Esters; Prostaglandins; Protein Kinase C; Rabbits; Staurosporine; Time Factors | 1992 |
Medical treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Androgen Antagonists; Androstenes; Azasteroids; Buserelin; Finasteride; Goserelin; Humans; Leuprolide; Male; Prostatic Hyperplasia | 1991 |
Pulmonary endometriosis: conservative treatment with GnRH agonists.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hemoptysis; Hormones; Humans; Leuprolide; Lung Neoplasms; Pneumothorax; Triptorelin Pamoate | 1991 |
Maximal androgen blockade in prostatic cancer.
Topics: Androgen Antagonists; Buserelin; Flutamide; Goserelin; Humans; Imidazoles; Imidazolidines; Leuprolide; Male; Orchiectomy; Prostatic Neoplasms | 1991 |
Gonadotropin-releasing hormone agonists induce meiotic maturation and degeneration of oocytes in the in vitro perfused rabbit ovary.
Topics: Animals; Buserelin; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Hormones; Leuprolide; Meiosis; Oocytes; Ovary; Rabbits; Reference Values; Triptorelin Pamoate | 1991 |
Chromosome studies in human unfertilized oocytes and uncleaved zygotes after treatment with gonadotropin-releasing hormone analogs.
Topics: Adult; Buserelin; Chromosome Mapping; Cleavage Stage, Ovum; Female; Fertilization; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocytes; Ploidies; Zygote | 1991 |
Effects of gonadotropin-releasing hormone agonists on meiotic maturation of follicle-enclosed oocytes in rabbits.
Topics: Animals; Buserelin; Chorionic Gonadotropin; Female; Gonadotropin-Releasing Hormone; In Vitro Techniques; Indomethacin; Leuprolide; Meiosis; Oocytes; Ovarian Follicle; Prostaglandins; Rats | 1990 |
[Hormone therapy of male genital cancer (prostatic cancer)].
Topics: Buserelin; Chlormadinone Acetate; Estramustine; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nitrogen Mustard Compounds; Prostatic Neoplasms | 1987 |
[Regulation of aromatase activity by gonadotropin-releasing hormone and its agonists in cultured rat granulosa cells].
Topics: Animals; Aromatase; Buserelin; Cells, Cultured; Dose-Response Relationship, Drug; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Granulosa Cells; Leuprolide; Pituitary Hormone-Releasing Hormones; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1989 |
[Testicular endocrine function in patients with prostatic cancer receiving medical castration by long-term administration of LH-RH agonists].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Buserelin; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Testis; Testosterone | 1989 |
[Clinical and endocrinological studies of the luteinizing hormone-releasing hormone analogue therapy in prostatic cancer patients].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgens; Antineoplastic Agents; Buserelin; Dihydrotestosterone; Drug Evaluation; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Testosterone | 1989 |
[Studies on endocrine therapy of endometriosis].
Topics: Animals; Buserelin; Danazol; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pregnadienes; Rats; Rats, Inbred Strains | 1989 |
Effect of GnRH agonists on the thymus in female rats.
Topics: Animals; Bone Marrow; Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Leuprolide; Organ Size; Rats; Rats, Inbred Strains; Spleen; Thymus Gland | 1989 |
Clinical appreciation of LHRH analogue formulations.
Topics: Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Triptorelin Pamoate | 1989 |
Distribution of gonadrotropin releasing hormone agonist binding sites in the rat central nervous system.
Topics: Animals; Autoradiography; Brain; Brain Mapping; Buserelin; Female; Gonadotropin-Releasing Hormone; Leuprolide; Pituitary Hormone-Releasing Hormones; Rats; Rats, Inbred Strains; Receptors, LHRH | 1988 |
[Treatment of carcinoma of the prostate with analogs of LHRH].
Topics: Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate | 1986 |
Commercially available analogues of GnRH and LH secretion.
Topics: Animals; Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Leuprolide; Luteinizing Hormone; Ovariectomy; Pituitary Gland; Rats; Rats, Inbred Strains | 1988 |
Treatment of breast cancer with gonadotropin-releasing hormone.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Tamoxifen | 1986 |
Pre-treatment testosterone levels: significance in androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Buserelin; Carcinoma; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Hydroxyproline as a marker for following patients with metastatic prostate cancer.
Topics: Bone Neoplasms; Buserelin; Creatinine; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hydroxyproline; Leuprolide; Male; Prostatic Neoplasms | 1988 |
Management of metastatic prostatic cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Castration; Cyclophosphamide; Diethylstilbestrol; Estramustine; Gonadotropin-Releasing Hormone; Hormones; Humans; Leuprolide; Male; Neoplasm Metastasis; Prostatic Neoplasms | 1985 |
[What is safe in the therapy of advanced prostatic cancer?].
Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Combined Modality Therapy; Estradiol Congeners; Estramustine; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Lymphatic Metastasis; Male; Neoplasm Staging; Orchiectomy; Prognosis; Prostate; Prostatectomy; Prostatic Neoplasms | 1985 |
Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man.
Topics: Administration, Intranasal; Adult; Androgens; Animals; Buserelin; Circadian Rhythm; Dose-Response Relationship, Drug; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Leydig Cells; Luteinizing Hormone; Male; Progestins; Rats; Receptors, Cell Surface; Receptors, LH; Receptors, LHRH; Spermatogenesis; Testis; Triptorelin Pamoate | 1980 |
Newer methods of hormonal therapy for prostate cancer.
Topics: Adenocarcinoma; Aminoglutethimide; Androgen Antagonists; Bone Neoplasms; Buserelin; Flutamide; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms | 1984 |
Inhibition of progesterone secretion during the luteal phase by two luteinizing hormone-releasing hormone agonists in Macaca fascicularis.
Topics: Animals; Buserelin; Cattle; Estradiol; Female; Gonadotropin-Releasing Hormone; Leuprolide; Luteal Phase; Macaca fascicularis; Menstruation; Progesterone; Rabbits | 1980 |
Occult ovarian failure.
Topics: Buserelin; Contraceptives, Oral; Dexamethasone; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Goserelin; Growth Hormone; Growth Substances; Humans; Infertility, Female; Leuprolide; Oocyte Donation; Pregnancy; Primary Ovarian Insufficiency | 1994 |
Kinetic analysis of prostatic volume in patients with stage D prostatic cancer treated with LHRH analogues in relation to prognosis.
Topics: Aged; Aged, 80 and over; Buserelin; Disease Progression; Follicle Stimulating Hormone; Humans; Kinetics; Leuprolide; Luteinizing Hormone; Male; Predictive Value of Tests; Prognosis; Prostate; Prostatic Neoplasms; Survival Analysis | 1995 |
Follicle cyst formation after administration of different gonadotrophin-releasing hormone analogues for assisted reproduction.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Menotropins; Ovarian Cysts; Pregnancy; Triptorelin Pamoate | 1994 |
Effects of GnRH analogs on six ovarian cancer cell lines in culture.
Topics: Analysis of Variance; Animals; Binding Sites; Binding, Competitive; Buserelin; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Leuprolide; Luteinizing Hormone; Ovarian Neoplasms; Pituitary Gland; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tumor Cells, Cultured | 1994 |
Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
Topics: Adult; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Luteinizing Hormone; Triptorelin Pamoate | 1993 |
Effect of LHRH analog on the seminal vesicles evaluated by transrectal sonography.
Topics: Aged; Aged, 80 and over; Buserelin; Follicle Stimulating Hormone; Humans; Leuprolide; Luteinizing Hormone; Male; Prostate; Prostatic Neoplasms; Seminal Vesicles; Testosterone | 1993 |
Statistical rubato and confidence intervals.
Topics: Buserelin; Confidence Intervals; Female; Fertilization in Vitro; Humans; Leuprolide; Ovarian Follicle | 1993 |
Resumption of menstruation after amenorrhea in women treated by endometrial ablation and myometrial resection.
Topics: Amenorrhea; Buserelin; Danazol; Electrocoagulation; Endometrium; Female; Follow-Up Studies; Goserelin; Humans; Leuprolide; Menorrhagia; Myometrium; Postoperative Complications; Preoperative Care; Retrospective Studies; Time Factors; Treatment Failure | 1997 |
Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents, Hormonal; Buserelin; Chemotherapy, Adjuvant; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; Infertility, Female; Injections, Intramuscular; Leiomyoma; Leuprolide; Nafarelin; Pregnancy; Pregnancy Rate; Retrospective Studies; Time Factors; Triptorelin Pamoate; Uterine Neoplasms | 1997 |
Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
Topics: Apoptosis; Buserelin; Endometrial Neoplasms; fas Receptor; Female; Gene Expression; Humans; Leuprolide; Oligopeptides; Ovarian Neoplasms; Polymerase Chain Reaction; Receptors, LHRH; RNA-Directed DNA Polymerase; RNA, Messenger; Tumor Cells, Cultured | 1998 |
Recovery and maturation of immature oocytes in patients at risk for ovarian hyperstimulation syndrome.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Granulosa Cells; Humans; Infertility, Female; Infertility, Male; Leuprolide; Male; Menstrual Cycle; Oocytes; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Risk Factors | 1998 |
A comparison of three GnRH analogues in an IVF programme.
Topics: Buserelin; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormones; Humans; Leuprolide; Nafarelin; Ovary; Pituitary Gland; Time Factors | 2000 |
Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro.
Topics: Apoptosis; Benzimidazoles; Buserelin; Coloring Agents; DNA Fragmentation; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Dyes; Humans; Leuprolide; Propidium | 2000 |
Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunction.
Topics: Adult; Buserelin; CA-125 Antigen; Cinnamomum zeylanicum; Danazol; Endometriosis; Estrogen Antagonists; Female; Hormones; Humans; Hyperthyroidism; Japan; Leuprolide; Magnoliopsida; Medicine, East Asian Traditional; Nafarelin; Phytotherapy; Plant Extracts; Thyrotropin; Thyroxine; Triiodothyronine | 2000 |
Gonadotropin-releasing hormone analogue therapy for peritoneal inclusion cysts after gynecological surgery.
Topics: Adult; Buserelin; Cysts; Female; Genitalia, Female; Humans; Hysterectomy; Leiomyoma; Leuprolide; Magnetic Resonance Imaging; Middle Aged; Ovariectomy; Peritoneal Diseases; Postoperative Complications; Recurrence; Treatment Outcome; Ultrasonography; Uterine Neoplasms | 2000 |
[Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin].
Topics: Adult; Buserelin; Chorionic Gonadotropin; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteal Phase; Luteinizing Hormone; Nafarelin; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 2001 |
Metachromasia of the endocervical epithelium in women treated with gonadotropin releasing hormone agonist.
Topics: Adult; Antineoplastic Agents, Hormonal; Buserelin; Cervix Uteri; Epithelium; Female; Fluorescent Antibody Technique; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Staining and Labeling; Tolonium Chloride; Uterine Neoplasms | 2001 |
Decreased bone mineral density during GnRH analog therapy and polymorphism of estrogen receptor gene in precocious puberty.
Topics: Bone Density; Buserelin; Child; Child, Preschool; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Puberty, Precocious; Receptors, Estrogen | 1999 |
Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
Topics: Adult; Antineoplastic Agents, Hormonal; Aromatase; Buserelin; Danazol; Endometriosis; Estrogen Antagonists; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; In Vitro Techniques; Ki-67 Antigen; Leiomyoma; Leuprolide; Middle Aged; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; RNA, Neoplasm; Uterine Diseases; Uterine Neoplasms | 2003 |
Cytogenetic analysis of uterine leiomyoma: the size, histopathology and GnRHa-response in relation to chromosome karyotype.
Topics: Adult; Buserelin; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 7; Female; Gonadotropin-Releasing Hormone; Humans; Karyotyping; Leiomyoma; Leuprolide; Magnetic Resonance Imaging; Middle Aged; Nafarelin; Uterine Neoplasms | 2003 |
The effect of GnRH analogs on urinary incontinence after ablation of the ovaries in dogs.
Topics: Animals; Buserelin; Dog Diseases; Dogs; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Leuprolide; Luteinizing Hormone; Ovariectomy; Phenylpropanolamine; Sympathomimetics; Triptorelin Pamoate; Urinary Incontinence | 2003 |
Association of bone mineral density with vitamin D and estrogen receptor gene polymorphisms during GnRH agonist treatment.
Topics: Adult; Biomarkers; Bone Density; Bone Remodeling; Buserelin; Female; Gonadotropin-Releasing Hormone; Haplotypes; Humans; Leuprolide; Nafarelin; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Receptors, Calcitriol; Receptors, Estrogen | 2004 |
Long-term effects on bone mineral density and bone metabolism of 6 months' treatment with gonadotropin-releasing hormone analogues in Japanese women: comparison of buserelin acetate with leuprolide acetate.
Topics: Absorptiometry, Photon; Adult; Bone and Bones; Bone Density; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Japan; Leuprolide; Lumbar Vertebrae; Osteocalcin; Osteoporosis; Time Factors; Uterus | 2005 |
The experiences of men receiving androgen deprivation treatment for prostate cancer: a qualitative study.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Buserelin; Drug Therapy; Humans; Interview, Psychological; Leuprolide; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Quality of Life; Sexuality; Social Identification; Tosyl Compounds | 2005 |
Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage.
Topics: Androstenedione; Antibiotics, Antineoplastic; Buserelin; Dose-Response Relationship, Drug; Doxorubicin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Granulosa Cells; Humans; Leuprolide | 2007 |
[Endometriosis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Buserelin; Complementary Therapies; Contraceptive Agents, Female; Cyclooxygenase 2 Inhibitors; Dysmenorrhea; Endometriosis; Female; Fertility Agents, Female; Humans; Infertility, Female; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Postoperative Care; Pregnancy; Time Factors | 2007 |
Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Goserelin; Humans; Leuprolide | 2008 |
Watchful waiting beats androgen deprivation therapy in early prostate cancer.
Topics: Aged; Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Buserelin; Drug Prescriptions; Flutamide; Humans; Imidazolidines; Leuprolide; Male; Patient Education as Topic; Patient Satisfaction; Prostatic Neoplasms; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis | 2008 |
Successful long-term management of adenomyosis associated with deep thrombosis by low-dose gonadotropin-releasing hormone agonist therapy.
Topics: Administration, Intranasal; Adult; Buserelin; Drug Administration Schedule; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Venous Thrombosis | 2009 |
GnRH receptor and peritoneal plasmin activity.
Topics: Buserelin; Cells, Cultured; Enzyme Activation; Fibrinolysin; Gene Expression; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Peritoneum; Plasminogen Activator Inhibitor 1; Receptors, LHRH; Tissue Plasminogen Activator | 2010 |
Use of collision induced dissociation mass spectrometry as a rapid technique for the identification of pharmacologically active peptides in pharmacopoeial testing.
Topics: Buserelin; Chemistry, Pharmaceutical; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Aspart; Insulin Lispro; Leuprolide; Mass Spectrometry; Models, Chemical; Peptides; Protein Structure, Tertiary; Technology, Pharmaceutical | 2011 |
Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Body Mass Index; Buserelin; Drug Therapy, Combination; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Retrospective Studies; Testosterone; Treatment Outcome | 2012 |
[Role of ovarian suppression in the combined treatment of breast cancer patients in premenopause].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Leuprolide; Middle Aged; Ovary; Perimenopause; Premenopause; Survival Analysis; Treatment Outcome; Triptorelin Pamoate | 2013 |
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2015 |
Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study.
Topics: Adenomyosis; Adult; Biomarkers; Bone Remodeling; Bone Resorption; Buserelin; Diphosphonates; Female; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Leiomyoma; Leuprolide; Middle Aged; Pilot Projects; Retrospective Studies; Uterine Neoplasms | 2016 |
INN Common stem: -relin.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Terminology as Topic; Triptorelin Pamoate | 2017 |
Accelerated Forced Degradation of Therapeutic Peptides in Levitated Microdroplets.
Topics: Buserelin; Deamino Arginine Vasopressin; Drug Compounding; Drug Stability; Hot Temperature; Hydrogen-Ion Concentration; Kinetics; Leuprolide; Octreotide; Particle Size; Protein Stability; Proteolysis; Workflow | 2020 |
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries.
Topics: Androgen Antagonists; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Triptorelin Pamoate; United States; United States Food and Drug Administration | 2023 |